InvestorsHub Logo
Followers 49
Posts 3257
Boards Moderated 0
Alias Born 10/28/2012

Re: JPetroInc post# 115183

Thursday, 06/11/2015 10:45:32 PM

Thursday, June 11, 2015 10:45:32 PM

Post# of 130505
Probably has a few connections from his previous employers.
From his Linked-in page:

Experience

Managing Partner
BioPharma Strategy Advisors
2011 – Present (4 years)San Jose, CA
Strategic and Market Advisory to global pharma, biotech, CRO, Law firms, Accounting firms and Foundations for positioning their assets, technology or services

Executive In Residence
SRI International
May 2012 – December 2014 (2 years 8 months)Menlo Park, California
Commercialization (License/Spin-Out) of life science related (biotech, medtech, diagnostics) innovations developed internally at SRI International.

Chief Business Officer
KineMed
April 2012 – April 2014 (2 years 1 month)Emeryville
KineMed is a biomarker discovery and clinical diagnostics company in Emeryville, CA
(Open)1 recommendation
Lila Taylor
Lila Taylor
Chief Business Officer at Demy-Colton Life Science Advisors
In addition to being one of the best connected professionals in the biotechnology and pharmaceutical industry, Ravi’s breadth of knowledge encompasses both the scientific and business development aspects of the field. Ravi is particularly...View

Business Development Advisor
Aduro
October 2010 – April 2012 (1 year 7 months)Berkeley, CA

CoFounder & CEO
Navya
August 2010 – March 2012 (1 year 8 months)San Francisco Bay Area

Managing Director
Adjuvant Global Advisors
2008 – 2011 (3 years)San Francisco Bay Area

CoFounder & Chief Business Officer
C2N Diagnostics
September 2007 – July 2008 (11 months)Greater St. Louis Area

CoFounder & COO
LifeTech Innovations
February 2007 – July 2008 (1 year 6 months)San Jose, CA
# Strategic Consulting, including business advisory, business management and alliance management.
# Advising biotechnology and specialty pharma companies to develop technology and product development opportunities.
# Contract negotiation, execution of alliances for in-licensing and out-licensing assets and proprietary technologies.
# Developing an Asia strategy for biotechs, pharma as well as VC's and Investment Banks and help raise funds to invest in up and coming asian life science companies.

President
RK Consulting
September 2006 – February 2007 (6 months)

Executive Director
Johnson & Johnson / ALZA
2004 – 2007 (3 years)Mountain View, CA

Global Head, Strategic Analysis & KM
Pfizer Global R&D
1991 – 2004 (13 years)New London/Norwich, Connecticut Area

Asst. Prof. Biochem & Medicine
Cornell University Med College
1986 – 1991 (5 years)